about
Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.Malaria during pregnancy and foetal haematological status in Blantyre, MalawiScheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized ControlSeverity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and ZimbabweAcute HIV infection among pregnant women in MalawiDifferent regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission.The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population."I can say that during the past years the college has produced excellent researchers....interview by Thengo KavinyaA pilot study to determine the normal haematological indices for young Malawian adults in Blantyre, Malawi.Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmissionPostnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variantsIn-vivo parasitological response to sulfadoxine-pyrimethamine in pregnant women in southern MalawiMaternal-fetal DNA admixture is associated with intrapartum mother-to-child transmission of HIV-1 in Blantyre, MalawiThe use of technology enhanced learning in health research capacity development: lessons from a cross country research partnership.Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother-infant pairs.Socio-demographic characteristics associated with HIV and syphilis seroreactivity among pregnant women in Blantyre, Malawi, 2000-2004.Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C.Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges.Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study.Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.Qualitative study to develop processes and tools for the assessment and tracking of African institutions' capacity for operational health research.Using a simplified human immunodeficiency virus type 1 p24 antigen assay to diagnose pediatric HIV-infection in Malawi.Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.Changing times? Gender roles and relationships in maternal, newborn and child health in Malawi.Risk factors and mechanisms of preterm delivery in Malawi.Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization.Supporting capacity for research on malaria in Africa.Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults.Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.Analysis of rural health centres preparedness for the management of diabetic patients in Malawi.Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in -negative HIV-infected Malawian adults stabilized on antiretroviral therapyPharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian AdultsP06-06. Capacity building for HIV vaccine trials in Africa through South-South collaborationThe assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa
P50
Q24810804-77284B3B-9A8E-4E0A-802B-006BB794A377Q24815923-56D75B29-9540-459C-B680-F3683FC1E432Q28554025-9181721E-47B6-4324-8E67-7DE09F55266FQ30222338-07619E21-41A9-492E-989E-C57DF9E3BFF0Q33688086-32A8870E-1AE0-481A-B3CA-4D60A52F9CD1Q33829950-8071357A-481C-46C4-9025-ABD608CECF05Q35077772-BA8626CA-95B4-4729-B1B0-C31056681809Q35140408-7D9CEA42-D48E-4FE8-9E75-49972D16E32BQ35938528-3C5AD1DE-3B37-4726-A504-D6E6BBAE4B22Q36397770-220FD793-3955-45D3-A7B7-5A06AC1B66B8Q36421344-1E7D2DB3-5BD9-4B05-B819-A5F16C58D1BFQ36588632-F30457A5-D55B-43A4-9E96-71927B01F1B1Q36736817-7353E32F-0755-4EC6-B837-697648C46580Q36743918-721B6BB7-B7E3-4E5F-A936-8213B37B32EAQ36886579-FBBA07A5-3834-4823-B4B4-B533F23029D6Q37119372-F11D0E9B-C965-4F53-8977-F69C6E2C5DCBQ37383272-8696EB40-E647-46D0-9431-0E15176FB06CQ37391227-0A43C0E0-A8A1-4C80-8702-696A9B9B01F7Q37460075-9D7863C7-2AED-4039-9DFB-EF0B37257E46Q38632443-A0ABF633-31BB-4783-8655-D9DAE84CE133Q38789604-B03A1A1B-3057-4338-9C5B-38B86EB8A60CQ38789608-A9F43F34-1FB2-45CC-AD89-A35836747E61Q39341627-C076E53A-DD29-4BC6-81EF-78FC7703FEF3Q39514602-239A76B4-5E00-49E4-975A-93E73C9F99BBQ40470650-639DF897-2250-4B5E-901D-06C16EC9D8CEQ41580987-7C40207E-6F2B-4146-B798-8175F75CAB59Q41839331-8837D573-23CB-4380-AF7A-E5423541E9BBQ41942889-920ACC33-ABF9-4C98-A42E-2C74C5CC659EQ41994158-CCC65030-70D6-452B-82BF-63EAACC7B373Q44993684-797CAD48-D6FE-4D2F-9D70-3FCA1B5BA937Q45746222-7CB5C17D-2F78-41D2-A2A8-90A9B3748D70Q52584308-50F01334-0B48-409A-BCAC-BB6D3CF97146Q54212174-5AD6EF87-15B1-4917-BD9B-751E6285BE79Q54260387-D62502A5-9BC3-414A-BB24-DA8825D6CFE3Q55080591-D4C87857-ACB5-439D-9A05-A7F7A61732AEQ55422461-370A3F42-EAC8-4D71-95DC-8DCFA8B53D57Q56339581-9941B3D8-C6B0-4E4C-915C-7757AED7F4CCQ56355681-72F4CA8A-EA78-4AB5-B03F-4E36FB1ECC7BQ56986699-A0210B76-D567-423E-9300-8DD827F01563Q60915761-5AC626D5-A4B4-4355-B6F0-FAD7F626EF27
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Victor Mwapasa
@ast
Victor Mwapasa
@en
Victor Mwapasa
@es
Victor Mwapasa
@nl
type
label
Victor Mwapasa
@ast
Victor Mwapasa
@en
Victor Mwapasa
@es
Victor Mwapasa
@nl
prefLabel
Victor Mwapasa
@ast
Victor Mwapasa
@en
Victor Mwapasa
@es
Victor Mwapasa
@nl
P106
P21
P31
P496
0000-0002-2748-8902